A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 13,045 shares of ATAI stock, worth $15,654. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,045
Previous 13,674 4.6%
Holding current value
$15,654
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$1.16 - $1.64 $729 - $1,031
-629 Reduced 4.6%
13,045 $15,000
Q2 2024

Jul 26, 2024

BUY
$1.27 - $2.6 $17,365 - $35,552
13,674 New
13,674 $18,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $199M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.